TD

Trinadhareddy D

Active Director Director DIN 00201421
DIN 00201421 First appointment Jun 1995 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1995
Shareholding value •••• Premium profile

About Trinadhareddy D

Data last updated:

Trinadhareddy D is a Director at Veras Pharmaceuticals Private Limited (since 1995). The company operates in Pharma. Veras Pharmaceuticals Private Limited reported revenue of ₹36.4 Lakh (FY 2022).

DIN 00201421
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 1995
Oldest Company Age 35 yrs
Largest company Veras Pharmaceuticals Private Limited · ₹36.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 19951991₹36.4 Lakh (FY 2022)Active

Board colleagues of Trinadhareddy D

Directorship timeline

Open interactive timeline →
Veras Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Trinadhareddy D

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trinadhareddy D

Trinadhareddy D currently holds 1 directorship: Veras Pharmaceuticals Private Limited (Director, since 27 Jun 1995, revenue ₹36.4 Lakh (FY 2022)).

Trinadhareddy D was first appointed on 27 Jun 1995 as Director at Veras Pharmaceuticals Private Limited.

The current boards of Trinadhareddy D's companies include Ranga Rao Maturi (Veras Pharmaceuticals Private Limited), Venkateswara Rao Vulli (Veras Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available